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Is therapy based on endoscopy results 
better than empiric therapy for dyspepsia?
■ Evidence summary
Though individual studies have suggested
that therapy based on endoscopy performed
before any other study (early endoscopy)
may be superior to empiric antisecretory
therapy and as efficacious as a “test and
treat” strategy in symptom relief, a
Cochrane systematic review of 20 RCTs (11
in primary care settings) provides the best
evidence on the role of early endoscopy.1
A subgroup analysis of 5 RCTs, which
compared early endoscopy with empiric
antisecretory therapy (typically for 4
weeks), revealed that early endoscopy
demonstrated a trend towards improve-
ment in self-reported symptoms and in 
dyspepsia symptom relief scores, but the
difference was not statistically significant
(relative risk [RR]=0.89; 95% confidence
interval [CI], 0.77–1.1). Because each study
Test-and-treat for H pylori
a reasonable first option
Guidelines for treating dyspepsia have to consider
several factors: clinical outcomes, risk vs benefit to
the patient, direct and indirect medical costs, and
patient preference and satisfaction. This well-
constructed review clearly demonstrates there is
no significant difference in symptom control
between early endoscopy and empiric acid 
suppression or testing and treating for H pylori.
The evidence regarding 2 other outcomes—patient
satisfaction and cost (especially if the indirect cost
of sick days is considered)—is less clear.
In my experience, testing and treating for 
H pylori is a reasonable first option, which often
avoids long courses of antisecretory therapy or
costly endoscopy. I treat patients who are negative
for H pylori with 8 weeks of acid suppression ther-
apy, and refer those with persistent symptoms for
endoscopy. I follow patients carefully and try to
distinguish between symptoms of dyspepsia and
reflux, which requires longer courses of acid 
suppression. For patients with alarm symptoms, 
I recommend early endoscopy.
Wail Malaty, MD
Mountain Area Health Education Center, Rural Track Family
Practice Residency, Hendersonville, NC
In the initial management of dyspepsia for patients
without “alarm” symptoms (weight loss, recurrent
vomiting, dysphagia, anemia, evidence of 
bleeding, onset of dyspepsia after age 45 years),
therapy based on the results of early endoscopy
was not better than empiric acid suppression (anti-
secretory therapy) or a Helicobacter pylori “test
and treat” strategy in reducing symptoms or
improving quality of life (strength of recomm-
endation [SOR]: A, based on a systematic review).
Results from studies of patient satisfaction 
comparing early endoscopy with empiric 
medication therapy are conflicting (SOR: A, based
on 2 randomized controlled trials [RCTs]). 
Though formal cost analyses are not available,
a strategy using “test and treat,” as opposed to
early endoscopy, results in significantly fewer endo-
scopies, which when formally evaluated, may trans-
late into a more cost-effective strategy of care (SOR:
A, based on a systematic review). Long-term follow-
up suggests that patients receiving “test and treat”
therapy may require fewer antisecretory medication
prescriptions compared with patients receiving early
endoscopy (SOR: B, based on a single RCT).
Kevin Rich, MD
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used different symptom scores, the relative
risk as calculated may under-represent the
true benefit of early endoscopy when com-
pared with empiric antisecretory therapy. 
When patient satisfaction was evaluat-
ed, results were dependent on the location
of care. In a primary care setting, patients
undergoing early endoscopy were as satis-
fied as those receiving empiric antisecreto-
ry therapy.2 In a trial of 414 patients ran-
domized after referral to specialty care,
patients in the early endoscopy group were
more satisfied with their medical care than
those receiving empiric antisecretory thera-
py (RR=0.13; 95% CI, 0.06–0.29).3
Results from studies comparing the
benefits of H pylori “test and treat” strate-
gies to early endoscopy are conflicting. A
subgroup analysis reported on 3 RCTs
from both primary and secondary settings
with 931 patients comparing H pylori “test
and treat” to initial endoscopy. It found no
significant difference in symptom reduction
(RR=1.06; 95% CI, 0.98–1.26).1 A recent
follow-up study of 1 of the trials included
in the Cochrane systematic review reported
on outcomes of a “test and treat” vs early
endoscopy strategy at 6 years. There was
no difference in days without symptoms
demonstrated between the 2 groups (mean
difference=0.05; 95% CI, –0.03 to 0.14
days).4 Self-reported symptom tracking and
a poor response rate (62%) to patient ques-
tionnaires reduces the strength of this
study’s conclusions.
Formal cost-effective analyses compar-
ing the “test and treat” with early
endoscopy strategy have not been done. A
subgroup analysis of 4 trials from the
Cochrane review (1 from primary care)
demonstrated a significant reduction of the
number of endoscopies among patients
receiving “test and treat” care vs those
receiving early endoscopy (RR=0.23; 95%
CI, 0.12–0.44). In the long-term follow-up
study, fewer antisecretory medication pre-
scriptions were needed by those patients in
the “test and treat” group (P=.047).4 These
figures are more robust; they were obtained
from national registry data rather than per-
sonal recall and questionnaire submission.
Recommendations from others
Guidelines from the American Gastro-
enterological Association for the initial
approach to young patients with dyspepsia
without alarm symptoms is to first “test and
treat” for those testing positive for H pylori,
prescribe empiric antisecretory therapy for
those testing negative, and proceed with
endoscopy for recurrent or persistent dys-
pepsia at 4 to 8 weeks.5 The American
Society for Gastrointestinal Endoscopy does
not recommend any of initial endoscopy,
empiric antisecretory therapy, or “test and
treat” over another for the reduction of
symptoms.6 The British Society of Gastro-
enterology recommends that initial manage-
ment of dyspepsia consist of empiric acid
suppression and H pylori testing. Persons
testing positive for H pylori should undergo
endoscopy.7 The Institute for Clinical
Systems Improvement recommends nonur-
gent upper endoscopy for those aged 50
years and older with symptoms of uncom-
plicated dyspepsia. They recommend initial
H pylori testing and treating those with pos-
itive results, and empiric proton pump
inhibitor treatment for 4 weeks for those
who are H pylori–negative.8
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The “test and
treat” strategy, 
as opposed to
early endoscopy,
leads to fewer 
endoscopies—
and it may 
be more 
cost-effective
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